Home
About us
Pronova BioPharma in brief
Production facilities
History
Our business concept
Vision, values and strategy
Health, safety and environment
Human resources
Management team
Board of directors
Annual report
Product
Omacor/Lovaza
Production process
Market
Distribution and partners
Research & development
Approach to R&D
R&D programmes
Quality
Ensuring excellent quality
Quality Control
Quality Assurance
Audit programs
Pharmacovigilance
News
Press releases archive
Media
Media contact
Fact sheet
Fact sheet in Norwegian
Photo archive
Investors
The share
Stock market announcements
Reports and presentations
Shareholder information
Top 20 shareholders
Policies
Dividend policy
Investor relations policy
Articles of association
General meeting
Registrar
Corporate governance
Analytical coverage
Subscribe
Contact information IR
Careers
General application
What we offer
Meet some of our people
Vacancies
Contact
Contact details
Henvendelser om Omacor i Norge
You are here:
Home
/
News
Førsteklasses produksjonsresultater ga god start på 2009
Read more
Press releases
2. Jul 2009 10:51:
Mandatory notification of trade
30. Jun 2009 16:49:
Pronova BioPharma appoints Morten Jurs as new CEO
22. Jun 2009 08:30:
Capital markets day Wednesday 9 September 2009
14. May 2009 11:06:
MANDATORY NOTIFICATION OF TRADE
7. May 2009 07:49:
Mandatory notification of trade
6. May 2009 07:00:
Mandatory notification of trade, 5 May, 2009
5. May 2009 14:18:
Minutes from the annual general meeting
5. May 2009 07:00:
Excellent production performance gave strong start to 2009
Press releases archive
Copyright 2007
©
Pronova BioPharma ASA
idium
web publishing
